TriangleNCT00721123 · OUTCOME
Percentage of Participants With at Least a 5-point Improvement From Baseline in Quality of Life Using the 36-Item Short-Form Health Survey (SF-36) Over Time, Through 264 Weeks
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- Measure
- NUMBER
- Unit
- Percentage of Participants
- Interval / dispersion
- Not reported
- Time frame
- through 264 Weeks
What was measured
The SF-36 Health Survey is a standardized questionnaire consisting of 36 questions that measures patient-reported symptoms on 8 dimensions; it is used to assess health-related quality of life (HRQoL). The Physical Component Summary (PCS) score summarizes the subscales Physical Functioning, Role-Physical, Bodily Pain, and General Health. The Mental Component Summary (MCS) score summarizes the subscales Vitality, Social Functioning, Role-Emotional, and Mental Health. Each score was scaled from 0 to 100. A positive change score indicates better HRQoL. The percentage of participants with at least a 5-point improvement from baseline is presented for each subscale.
Analysis population: All exposure population, which includes all participants who entered the study and received at least one dose of tocilizumab at any time, with a score at the given time point.
Groups in this outcome
Week 24
Participants with scores at 24 weeks post-baseline.
Week 48
Participants with scores at 48 weeks post-baseline.
Week 108
Participants with scores at 108 weeks post-baseline.
Week 156
Participants with scores at 156 weeks post-baseline.
Week 204
Participants with scores at 204 weeks post-baseline.
Week 264
Participants with scores at 264 weeks post-baseline.
| Group | Source count |
|---|---|
| Week 24 | 423 |
| Week 48 | 424 |
| Week 108 | 395 |
| Week 156 | 373 |
| Week 204 | 344 |
| Week 264 | 334 |
Reported measurements
SF-36 MCS
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Week 24 | 48.2 | Not reported | Not reported | Not reported | Not reported |
| Week 48 | 46.2 | Not reported | Not reported | Not reported | Not reported |
| Week 108 | 48.6 | Not reported | Not reported | Not reported | Not reported |
| Week 156 | 49.9 | Not reported | Not reported | Not reported | Not reported |
| Week 204 | 49.7 | Not reported | Not reported | Not reported | Not reported |
| Week 264 | 49.1 | Not reported | Not reported | Not reported | Not reported |
SF-36 PCS
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Week 24 | 63.8 | Not reported | Not reported | Not reported | Not reported |
| Week 48 | 69.1 | Not reported | Not reported | Not reported | Not reported |
| Week 108 | 71.1 | Not reported | Not reported | Not reported | Not reported |
| Week 156 | 71.3 | Not reported | Not reported | Not reported | Not reported |
| Week 204 | 73.3 | Not reported | Not reported | Not reported | Not reported |
| Week 264 | 71.3 | Not reported | Not reported | Not reported | Not reported |
Complete source fields
- classes
- categories
- measurements
- group Id
- OG000
- value
- 48.2
- group Id
- OG001
- value
- 46.2
- group Id
- OG002
- value
- 48.6
- group Id
- OG003
- value
- 49.9
- group Id
- OG004
- value
- 49.7
- group Id
- OG005
- value
- 49.1
- title
- SF-36 MCS
- categories
- measurements
- group Id
- OG000
- value
- 63.8
- group Id
- OG001
- value
- 69.1
- group Id
- OG002
- value
- 71.1
- group Id
- OG003
- value
- 71.3
- group Id
- OG004
- value
- 73.3
- group Id
- OG005
- value
- 71.3
- title
- SF-36 PCS
- denoms
- counts
- group Id
- OG000
- value
- 423
- group Id
- OG001
- value
- 424
- group Id
- OG002
- value
- 395
- group Id
- OG003
- value
- 373
- group Id
- OG004
- value
- 344
- group Id
- OG005
- value
- 334
- units
- Participants
- description
- The SF-36 Health Survey is a standardized questionnaire consisting of 36 questions that measures patient-reported symptoms on 8 dimensions; it is used to assess health-related quality of life (HRQoL). The Physical Component Summary (PCS) score summarizes the subscales Physical Functioning, Role-Physical, Bodily Pain, and General Health. The Mental Component Summary (MCS) score summarizes the subscales Vitality, Social Functioning, Role-Emotional, and Mental Health. Each score was scaled from 0 to 100. A positive change score indicates better HRQoL. The percentage of participants with at least a 5-point improvement from baseline is presented for each subscale.
- groups
- description
- Participants with scores at 24 weeks post-baseline.
- id
- OG000
- title
- Week 24
- description
- Participants with scores at 48 weeks post-baseline.
- id
- OG001
- title
- Week 48
- description
- Participants with scores at 108 weeks post-baseline.
- id
- OG002
- title
- Week 108
- description
- Participants with scores at 156 weeks post-baseline.
- id
- OG003
- title
- Week 156
- description
- Participants with scores at 204 weeks post-baseline.
- id
- OG004
- title
- Week 204
- description
- Participants with scores at 264 weeks post-baseline.
- id
- OG005
- title
- Week 264
- param Type
- NUMBER
- population Description
- All exposure population, which includes all participants who entered the study and received at least one dose of tocilizumab at any time, with a score at the given time point.
- reporting Status
- POSTED
- time Frame
- through 264 Weeks
- title
- Percentage of Participants With at Least a 5-point Improvement From Baseline in Quality of Life Using the 36-Item Short-Form Health Survey (SF-36) Over Time, Through 264 Weeks
- type
- SECONDARY
- unit Of Measure
- Percentage of Participants
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice